Fructose: A key factor in the development of metabolic syndrome and hypertension

Journal of Nutrition and Metabolism

Volumn 2013, Issue , 2013, Pages

  Khitan, Zeid ^a   Kim, Dong Hyun ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878720152     PISSN: 20900724     EISSN: 20900732     Source Type: Journal    
DOI: 10.1155/2013/682673     Document Type: Review

References (121)

1. Osler W., The Principles and Practice of Medicine 1895 2nd
2. Cory S., Ussery-Hall A., Griffin-Blake S., Easton A., Vigeant J., Balluz L., Garvin W., Greenlund K., Prevalence of selected risk behaviors and chronic diseases and conditions-steps communities, United States, 2006-2007. Morbidity and Mortality Weekly Report 2010 59 8 1 37 2-s2.0-77957314865
3. Fox C. S., Pencina M. J., Meigs J. B., Vasan R. S., Levitzky Y. S., D'Agostino R. B., Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: The Framingham Heart Study. Circulation 2006 113 25 2914 2918 2-s2.0-33747097918 10.1161/CIRCULATIONAHA.106.613828 (Pubitemid 44297232)
4. Kahn B. B., Flier J. S., Obesity and insulin resistance. The Journal of Clinical Investigation 2000 106 4 473 481 2-s2.0-0033849777 (Pubitemid 30666380)
5. Pan W. H., Flegal K. M., Chang H. Y., Yeh W. T., Yeh C. J., Lee W. C., Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. The American Journal of Clinical Nutrition 2004 79 1 31 39 2-s2.0-12344337734 (Pubitemid 41132059)
6. Johnson R. J., Perez-Pozo S. E., Sautin Y. Y., Manitius J., Sanchez-Lozada L. G., Feig D. I., Shafiu M., Segal M., Glassock R. J., Shimada M., Roncal C., Nakagawa T., Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocrine Reviews 2009 30 1 96 116 2-s2.0-60549110854 10.1210/er.2008-0033
7. Johnson R. J., Segal M. S., Sautin Y., Nakagawa T., Feig D. I., Kang D. H., Gersch M. S., Benner S., Sánchez-Lozada L. G., Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease1-3. The American Journal of Clinical Nutrition 2007 86 4 899 906 2-s2.0-35148825449 (Pubitemid 47538288)
8. Zhao F. Q., Keating A. F., Functional properties and genomics of glucose transporters. Current Genomics 2007 8 2 113 128 2-s2.0-34247842999 10.2174/138920207780368187 (Pubitemid 46690959)
9. Fox I. H., Kelley W. N., Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism 1972 21 8 713 721 2-s2.0-0015387184
10. Mäenpää P. H., Raivio K. O., Kekomäki M. P., Liver adenine nucleotides: fructose-induced depletion and its effect on protein synthesis. Science 1968 161 3847 1253 1254 2-s2.0-0014424849
11. Gustafson B., Adipose tissue, inflammation and atherosclerosis. Journal of Atherosclerosis and Thrombosis 2010 17 4 332 341 2-s2.0-77953509678
12. Murray R., Bender D., Botham K. M., Kennelly P. J., Rodwell V., Weil P. A., Harper's Illustrated Biochemistry 2003 New York, NY, USA
13. McGuinness O. P., Cherrington A. D., Effects of fructose on hepatic glucose metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 2003 6 4 441 448 2-s2.0-9244229841 10.1097/00075197-200307000-00014 (Pubitemid 40684597)
14. Lanaspa M. A., Sanchez-Lozada L. G., Cicerchi C., Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver. PLoS One 2012 7 10 e47948
15. Khosla U. M., Zharikov S., Finch J. L., Nakagawa T., Roncal C., Mu W., Krotova K., Block E. R., Prabhakar S., Johnson R. J., Hyperuricemia induces endothelial dysfunction. Kidney International 2005 67 5 1739 1742 2-s2.0-20244365646 10.1111/j.1523-1755.2005.00273.x (Pubitemid 40577708)
16. Sautin Y. Y., Nakagawa T., Zharikov S., Johnson R. J., Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. American Journal of Physiology 2007 293 2 C584 C596 2-s2.0-34547733397 10.1152/ajpcell.00600.2006 (Pubitemid 47235197)
17. Fiaschi E., Baggio B., Favaro S., Fructose-induced hyperuricemia in essential hypertension. Metabolism 1977 26 11 1219 1223 2-s2.0-0017745699 (Pubitemid 8210416)
18. Perheentupa J., Raivio K., Fructose-induced hyperuricaemia. The Lancet 1967 2 7515 528 531 2-s2.0-0014197037
19. Stirpe F., Della Corte E., Bonetti E., Abbondanza A., Abbati A., De Stefano F., Fructose-induced hyperuricaemia. The Lancet 1970 2 7686 1310 1311 2-s2.0-0014955496
20. Stanhope K. L., Havel P. J., Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Current Opinion in Lipidology 2008 19 1 16 24 2-s2.0-38149042079 10.1097/MOL.0b013e3282f2b24a
21. Raushel F. M., Cleland W. W., The substrate and anomeric specificity of fructokinase. The Journal of Biological Chemistry 1973 248 23 8174 8177 2-s2.0-0015733836
22. Diggle C. P., Shires M., Leitch D., Brooke D., Carr I. M., Markham A. F., Hayward B. E., Asipu A., Bonthron D. T., Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme. Journal of Histochemistry and Cytochemistry 2009 57 8 763 774 2-s2.0-69249216656 10.1369/jhc.2009.953190
23. Asipu A., Hayward B. E., O'Reilly J., Bonthron D. T., Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria. Diabetes 2003 52 9 2426 2432 2-s2.0-0041819987 10.2337/diabetes.52.9.2426 (Pubitemid 37059516)
24. Ishimoto T., Lanaspa M. A., Le M. T., Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proceedings of the National Academy of Sciences of the United States of America 2012 109 11 4320 4325
25. Diggle C. P., Shires M., McRae C., Crellin D., Fisher J., Carr I. M., Markham A. F., Hayward B. E., Asipu A., Bonthron D. T., Both isoforms of ketohexokinase are dispensable for normal growth and development. Physiological Genomics 2010 42 4 235 243 2-s2.0-78649723538 10.1152/physiolgenomics.00128.2010
26. Lê K. A., Faeh D., Stettler R., Ith M., Kreis R., Vermathen P., Boesch C., Ravussin E., Tappy L., A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. The American Journal of Clinical Nutrition 2006 84 6 1374 1379 2-s2.0-33845482041 (Pubitemid 44912820)
27. Mayatepek E., Hoffmann B., Meissner T., Inborn errors of carbohydrate metabolism. Best Practice and Research 2010 24 5 607 618 2-s2.0-77958101342 10.1016/j.bpg.2010.07.012
28. Froesch E. R., Disorders of fructose metabolism. Clinics in Endocrinology and Metabolism 1976 5 3 599 611 2-s2.0-0017139433
29. Bonthron D. T., Brady N., Donaldson I. A., Steinmann B., Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase). Human Molecular Genetics 1994 3 9 1627 1631 2-s2.0-0028142878 (Pubitemid 24295460)
30. Marriott B. P., Cole N., Lee E., National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. Journal of Nutrition 2009 139 6 1228S 1235S 2-s2.0-66749107383 10.3945/jn.108.098277
31. Park Y. K., Yetley E. A., Intakes and food sources of fructose in the United States. The American Journal of Clinical Nutrition 1993 58 5, supplement 737S 747S 2-s2.0-0027425939 (Pubitemid 23319971)
32. Bray G. A., Nielsen S. J., Popkin B. M., Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. The American Journal of Clinical Nutrition 2004 79 4 537 543 2-s2.0-2142815151 (Pubitemid 41103894)
33. Bray G. A., The epidemic of obesity and changes in food intake: the fluoride hypothesis. Physiology and Behavior 2004 82 1 115 121 2-s2.0-3242772094 10.1016/j.physbeh.2004.04.033 (Pubitemid 38968517)
34. Hu F. B., Malik V. S., Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence. Physiology and Behavior 2010 100 1 47 54 2-s2.0-77951023327 10.1016/j.physbeh.2010.01.036
35. Malik V. S., Schulze M. B., Hu F. B., Intake of sugar-sweetened beverages and weight gain: a systematic review. The American Journal of Clinical Nutrition 2006 84 2 274 288 2-s2.0-33748439003 (Pubitemid 44699135)
36. Morgan R. E., Does consumption of high-fructose corn syrup beverages cause obesity in children? Pediatric Obesity 2013 10.1111/j.2047-6310.2013. 00173.x
37. Stanhope K. L., Havel P. J., Fructose consumption: recent results and their potential implications. Annals of the New York Academy of Sciences 2010 1190 15 24 2-s2.0-77950275577 10.1111/j.1749-6632.2009.05266.x
38. Dolan L. C., Potter S. M., Burdock G. A., Evidence-based review on the effect of normal dietary consumption of fructose on development of hyperlipidemia and obesity in healthy, normal weight individuals. Critical Reviews in Food Science and Nutrition 2010 50 1 53 84 2-s2.0-77649196975
39. Forshee R. A., Anderson P. A., Storey M. L., Sugar-sweetened beverages and body mass index in children and adolescents: a meta-analysis. The American Journal of Clinical Nutrition 2008 87 6 1662 1671 2-s2.0-45749112463 (Pubitemid 351872628)
40. Ha V., Sievenpiper J. L., de Souza R. J., Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension 2012 59 4 787 795
41. Mattes R. D., Shikany J. M., Kaiser K. A., Allison D. B., Nutritively sweetened beverage consumption and body weight: a systematic review and meta-analysis of randomized experiments. Obesity Reviews 2011 12 5 346 365 2-s2.0-79954568550 10.1111/j.1467-789X.2010.00755.x
42. Sievenpiper J. L., de Souza R. J., Mirrahimi A., Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Annals of Internal Medicine 2012 156 4 291 304
43. Chen M., Pan A., Malik V. S., Hu F. B., Effects of dairy intake on body weight and fat: a meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition 2012 96 4 735 747
44. Ledoux T. A., Watson K., Barnett A., Nguyen N. T., Baranowski J. C., Baranowski T., Components of the diet associated with child adiposity: a cross-sectional study. Journal of the American College of Nutrition 2011 30 6 536 546
45. Schulze M. B., Manson J. E., Ludwig D. S., Colditz G. A., Stampfer M. J., Willett W. C., Hu F. B., Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. Journal of the American Medical Association 2004 292 8 927 934 2-s2.0-4143067005 10.1001/jama.292.8.927 (Pubitemid 39097202)
46. Sun S. Z., Anderson G. H., Flickinger B. D., Williamson-Hughes P. S., Empie M. W., Fructose and non-fructose sugar intakes in the US population and their associations with indicators of metabolic syndrome. Food and Chemical Toxicology 2011 49 11 2875 2882
47. Unger R. H., Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003 144 12 5159 5165 2-s2.0-0345374579 10.1210/en.2003-0870 (Pubitemid 37476041)
48. Zammit V. A., Waterman I. J., Topping D., McKay G., Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. Journal of Nutrition 2001 131 8 2074 2077 2-s2.0-0034905540 (Pubitemid 32720632)
49. Perez-Pozo S. E., Schold J., Nakagawa T., Sánchez-Lozada L. G., Johnson R. J., Lillo J. L., Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. International Journal of Obesity 2010 34 3 454 461 2-s2.0-77949541626 10.1038/ijo.2009.259
50. Jalal D. I., Smits G., Johnson R. J., Chonchol M., Increased fructose associates with elevated blood pressure. Journal of the American Society of Nephrology 2010 21 9 1543 1549 2-s2.0-77956552344 10.1681/ASN.2009111111
51. Nguyen S., Choi H. K., Lustig R. H., Hsu C. Y., Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. Journal of Pediatrics 2009 154 6 807 813 2-s2.0-65549147918 10.1016/j.jpeds.2009.01.015
52. Kim Y. H., Abris G. P., Sung M. K., Lee J. E., Consumption of sugar-sweetened beverages and blood pressure in the United States: the national health and nutrition examination survey 2003-2006. Clinical Nutrition Research 2012 1 1 85 93
53. Feig D. I., Mazzali M., Kang D. H., Nakagawa T., Price K., Kannelis J., Johnson R. J., Serum uric acid: a risk factor and a target for treatment? Journal of the American Society of Nephrology 2006 17 4, supplement 2 S69 S73 2-s2.0-33645463244 10.1681/ASN.2005121331
54. Feig D. I., Kang D. H., Johnson R. J., Medical progress: uric acid and cardiovascular risk. The New England Journal of Medicine 2008 359 17 1811 1821 2-s2.0-54949100735 10.1056/NEJMra0800885
55. Pereira M. A., Fulgoni V. L. III, Consumption of 100% fruit juice and risk of obesity and metabolic syndrome: findings from the national health and nutrition examination survey 1999-2004. Journal of the American College of Nutrition 2010 29 6 625 629
56. Champagne C. M., Broyles S. T., Moran L. D., Dietary intakes associated with successful weight loss and maintenance during the Weight Loss Maintenance trial. Journal of the American Dietetic Association 2011 111 12 1826 1835
57. Rosado J. L., Garcia O. P., Ronquillo D., Hervert-Hernandez D., Caamano M. C., Martinez G., Gutierrez J., Garcia S., Intake of milk with added micronutrients increases the effectiveness of an energy-restricted diet to reduce body weight: a randomized controlled clinical trial in Mexican women. Journal of the American Dietetic Association 2011 111 10 1507 1516
58. Disse S. C., Buelow A., Boedeker R. H., Keller K. M., Kim-Berger H. S., Wudy S. A., Zimmer K. P., Reduced prevalence of obesity in children with primary fructose malabsorption: a multicentre, retrospective cohort study. Pediatric Obesity 2013 10.1111/j.2047-6310.2013.00163.x
59. Walker R. W., Le K. A., Davis J., Alderete T. L., Cherry R., Lebel S., Goran M. I., High rates of fructose malabsorption are associated with reduced liver fat in obese African Americans. Journal of the American College of Nutrition 2012 31 5 369 374
60. Vázquez-Vela M. E. F., Torres N., Tovar A. R., White adipose tissue as endocrine organ and its role in obesity. Archives of Medical Research 2008 39 8 715 728 2-s2.0-55249098186 10.1016/j.arcmed.2008.09.005
61. Lefterova M. I., Lazar M. A., New developments in adipogenesis. Trends in Endocrinology and Metabolism 2009 20 3 107 114 2-s2.0-62949236601 10.1016/j.tem.2008.11.005
62. Gregoire F. M., Smas C. M., Sul H. S., Understanding adipocyte differentiation. Physiological Reviews 1998 78 3 783 809 2-s2.0-0031821520 (Pubitemid 28340604)
63. Rosen E. D., Walkey C. J., Puigserver P., Spiegelman B. M., Transcriptional regulation of adipogenesis. Genes and Development 2000 14 11 1293 1307 2-s2.0-0034214246 (Pubitemid 30397073)
64. Evans R. M., Barish G. D., Wang Y. X., PPARs and the complex journey to obesity. Nature Medicine 2004 10 4 355 361 2-s2.0-1942518840 10.1038/nm1025 (Pubitemid 38508511)
65. Kim J. Y., van de Wall E., Laplante M., Azzara A., Trujillo M. E., Hofmann S. M., Schraw T., Durand J. L., Li H., Li G., Jelicks L. A., Mehler M. F., Hui D. Y., Deshaies Y., Shulman G. I., Schwartz G. J., Scherer P. E., Obesity-associated improvements in metabolic profile through expansion of adipose tissue. The Journal of Clinical Investigation 2007 117 9 2621 2637 2-s2.0-34848872799 10.1172/JCI31021 (Pubitemid 47494363)
66. Martini C. N., Plaza M. V., Vila M. D. C., PKA-dependent and independent cAMP signaling in 3T3-L1 fibroblasts differentiation. Molecular and Cellular Endocrinology 2009 298 1-2 42 47 2-s2.0-57749200703 10.1016/j.mce.2008.10.023
67. Shen G. X., Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase. Canadian Journal of Physiology and Pharmacology 2010 88 3 241 248 2-s2.0-77950915621 10.1139/Y10-018
68. De Pauw A., Tejerina S., Raes M., Keijer J., Arnould T., Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. American Journal of Pathology 2009 175 3 927 939 2-s2.0-70349240364 10.2353/ajpath.2009.081155
69. Patti M. E., Corvera S., The role of mitochondria in the pathogenesis of type 2 diabetes. Endocrine Reviews 2010 31 3 364 395 2-s2.0-77954859197 10.1210/er.2009-0027
70. Berg A. H., Combs T. P., Du X., Brownlee M., Scherer P. E., The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine 2001 7 8 947 953 2-s2.0-0034881391 10.1038/90992 (Pubitemid 32756433)
71. Yamauchi T., Kamon J., Minokoshi Y., Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 2002 8 11 1288 1295 (Pubitemid 35373562)
72. Burt V. L., Whelton P., Roccella E. J., Brown C., Cutler J. A., Higgins M., Horan M. J., Labarthe D., Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995 25 3 305 313 2-s2.0-0028942436
73. Fields L. E., Burt V. L., Cutler J. A., Hughes J., Roccella E. J., Sorlie P., The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004 44 4 398 404 2-s2.0-4644242120 10.1161/01.HYP.0000142248.54761.56 (Pubitemid 39281486)
74. Taylor J., The hypertension detection and follow-up program: a progress report. Circulation Research 1977 40 5, supplement 1 I106 I109
75. Alper A. B. Jr., Chen W., Yau L., Srinivasan S. R., Berenson G. S., Hamm L. L., Childhood uric acid predicts adult blood pressure: The Bogalusa Heart Study. Hypertension 2005 45 1 34 38 2-s2.0-11244331349 10.1161/01.HYP. 0000150783.79172.bb (Pubitemid 40066410)
76. Masuo K., Kawaguchi H., Mikami H., Ogihara T., Tuck M. L., Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003 42 4 474 480 2-s2.0-0141962657 10.1161/01.HYP.0000091371.53502.D3 (Pubitemid 37237341)
77. Mellen P. B., Bleyer A. J., Erlinger T. P., Evans G. W., Nieto F. J., Wagenknecht L. E., Wofford M. R., Herrington D. M., Serum uric acid predicts incident hypertension in a biethnic cohort: The Atherosclerosis Risk in Communities Study. Hypertension 2006 48 6 1037 1042 2-s2.0-33751078313 10.1161/01.HYP.0000249768.26560.66 (Pubitemid 44772705)
78. Nagahama K., Inoue T., Iseki K., Touma T., Kinjo K., Ohya Y., Takishita S., Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertension Research 2004 27 11 835 841 2-s2.0-14644444622 10.1291/hypres.27.835 (Pubitemid 40309449)
79. Sundström J., Sullivan L., D'Agostino R. B., Levy D., Kannel W. B., Vasan R. S., Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005 45 1 28 33 2-s2.0-11244264034 10.1161/01.HYP.0000150784.92944.9a (Pubitemid 40066409)
80. Mazzali M., Hughes J., Kim Y. G., Jefferson J. A., Kang D. H., Gordon K. L., Lan H. Y., Kivlighn S., Johnson R. J., Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001 38 5 1101 1106 2-s2.0-0035723995 (Pubitemid 34252813)
81. Feig D. I., Soletsky B., Johnson R. J., Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. Journal of the American Medical Association 2008 300 8 924 932 2-s2.0-50449095362 10.1001/jama.300.8.924
82. Soletsky B., Feig D. I., Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension 2012 60 5 1148 1156
83. Farah V., Elased K. M., Chen Y., Key M. P., Cunha T. S., Irigoyen M. C., Morris M., Nocturnal hypertension in mice consuming a high fructose diet. Autonomic Neuroscience 2006 130 1-2 41 50 2-s2.0-33750967338 10.1016/j.autneu.2006.05.006 (Pubitemid 44750860)
84. De A. K., Senador D. D., Mostarda C., Irigoyen M. C., Morris M., Sympathetic overactivity precedes metabolic dysfunction in a fructose model of glucose intolerance in mice. American Journal of Physiology 2012 302 8 R950 R957
85. Hwang I., Ho H., Hoffman B. B., Reaven G. M., Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987 10 5 512 516 2-s2.0-0023493524 (Pubitemid 18011228)
86. Wolfe B. M., Ahuja S. P., Effects of intravenously administered fructose and glucose on splanchnic secretion of plasma triglycerides in hypertriglyceridemic men. Metabolism 1977 26 9 963 978 2-s2.0-0017655314 (Pubitemid 8178336)
87. Sato Y., Ito T., Udaka N., Kanisawa M., Noguchi Y., Cushman S. W., Satoh S., Immunohistochemical localization of facilitated-diffusion glucose transporters in rat pancreatic islets. Tissue and Cell 1996 28 6 637 643 2-s2.0-0030461281 10.1016/S0040-8166(96)80067-X (Pubitemid 27011027)
88. Teff K. L., Elliott S. S., Tschöp M., Kieffer T. J., Rader D., Heiman M., Townsend R. R., Keim N. L., D'Alessio D., Havel P. J., Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2963 2972 2-s2.0-2942638040 10.1210/jc.2003-031855 (Pubitemid 38766393)
89. Swarbrick M. M., Stanhope K. L., Elliott S. S., Graham J. L., Krauss R. M., Christiansen M. P., Griffen S. C., Keim N. L., Havel P. J., Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. British Journal of Nutrition 2008 100 5 947 952 2-s2.0-53649104150 10.1017/ S0007114508968252
90. Rebollo A., Roglans N., Alegret M., Laguna J. C., Way back for fructose and liver metabolism: bench side to molecular insights. World Journal of Gastroenterology 2012 18 45 6552 6559
91. Goran M. I., Ulijaszek S. J., Ventura E. E., High fructose corn syrup and diabetes prevalence: a global perspective. Global Public Health 2013 8 1 55 64
92. Mukai Y., Kumazawa M., Sato S., Fructose intake during pregnancy up-regulates the expression of maternal and fetal hepatic sterol regulatory element-binding protein-1c in rats. Endocrine 2012 10.1007/s12020-012-9815-8
93. Perala M. M., Mannisto S., Kaartinen N. E., Kajantie E., Osmond C., Barker D. J., Valsta L. M., Eriksson J. G., Body size at birth is associated with food and nutrient intake in adulthood. PLoS One 2012 7 9 e46139
94. Koricanac G., Tepavcevic S., Romic S., Estradiol enhances effects of fructose rich diet on cardiac fatty acid transporter CD36 and triglycerides accumulation. European Journal of Pharmacology 2012 694 1-3 127 134
95. Zou M., Arentson E. J., Teegarden D., Koser S. L., Onyskow L., Donkin S. S., Fructose consumption during pregnancy and lactation induces fatty liver and glucose intolerance in rats. Nutrition Research 2012 32 8 588 598
96. Li H., Xu R., Peng X., Wang Y., Wang T., Association of glucokinase regulatory protein polymorphism with type 2 diabetes and fasting plasma glucose: a meta-analysis. Molecular Biology Reports 2013 40 6 3935 3942
97. Masotti A., Comment on: Visinoni et al. The role of liver fructose-1,6-bisphosphatase in regulating appetite and adiposity, Diabetes, vol. 61, pp. 1122-1132, 2012. Diabetes 2012 61 12, article e20
98. Marcus Y., Shefer G., Sasson K., Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model. Diabetes 2013 62 4 1121 1130
99. Merrins M. J., Bertram R., Sherman A., Satin L. S., Phosphofructo-2- kinase/fructose-2,6-bisphosphatase modulates oscillations of pancreatic islet metabolism. PLoS One 2012 7 4 e34036
100. Wilson-O'Brien A. L., Patron N., Rogers S., Evolutionary ancestry and novel functions of the mammalian glucose transporter (GLUT) family. BMC Evolutionary Biology 2010 10 1, article 152 2-s2.0-77952432489 10.1186/1471-2148-10-152
101. Buemann B., Toubro S., Holst J. J., Rehfeld J. F., Bibby B. M., Astrup A., D-Tagatose, a stereoisomer of D-fructose, increases blood uric acid concentration. Metabolism 2000 49 8 969 976 2-s2.0-0033897686 10.1053/meta.2000.7724 (Pubitemid 30641431)
102. Schaalan M. F., Effects of pioglitazone and/or simvastatin on circulating TNFalpha and adiponectin levels in insulin resistance. Journal of Immunotoxicology 2012 9 2 201 209
103. Puyo A. M., Borroni J. S., Boudou S., Santander Y., Carranza A., Donoso A. S., Peredo H. A., Metformin reduces vascular production of vasoconstrictor prostanoids in fructose overloaded rats. Autonomic and Autacoid Pharmacology 2012 32 1, part 2 9 14
104. Chou C. L., Pang C. Y., Lee T. J., Fang T. C., Direct renin inhibitor prevents and ameliorates insulin resistance, aortic endothelial dysfunction and vascular remodeling in fructose-fed hypertensive rats. Hypertension Research 2013 36 2 123 128
105. Li P., Koike T., Jiang H. Y., Wang Z. H., Kawata Y., Oshida Y., Acute treatment with candesartan cilexetil, an angiotensin II type 1 receptor blocker, improves insulin sensitivity in high-fructose-diet-fed rats. Hormone and Metabolic Research 2012 44 4 286 290
106. Abdulla M. H., Sattar M. A., Abdullah N. A., Johns E. J., The effect of losartan and carvedilol on renal haemodynamics and altered metabolism in fructose-fed Sprague-Dawley rats. Journal of Physiology and Biochemistry 2012 68 3 353 363
107. Guo Q., Mori T., Jiang Y., Hu C., Ohsaki Y., Yoneki Y., Nakamichi T., Ogawa S., Sato H., Ito S., Losartan modulates muscular capillary density and reverses thiazide diuretic-exacerbated insulin resistance in fructose-fed rats. Hypertension Research 2012 35 1 48 54
108. Yoshida D., Higashiura K., Shinshi Y., Satoh K., Hyakkoku M., Yoshida H., Miyazaki Y., Ura N., Shimamoto K., Effects of angiotensin II receptor blockade on glucose metabolism via AMP-activated protein kinase in insulin-resistant hypertensive rats. Journal of the American Society of Hypertension 2009 3 1 3 8 2-s2.0-58549091836 10.1016/j.jash.2008.08.002
109. Ran J., Hirano T., Fukui T., Saito K., Kageyama H., Okada K., Adachi M., Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance. Metabolism 2006 55 4 478 488 2-s2.0-33644935649 10.1016/j.metabol.2005.10.009
110. Jing F., Mogi M., Horiuchi M., Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction. Molecular and Cellular Endocrinology 2012 10.1016/j.mce.2012.03.005
111. Kalupahana N. S., Massiera F., Quignard-Boulange A., Ailhaud G., Voy B. H., Wasserman D. H., Moustaid-Moussa N., Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance. Obesity 2012 20 1 48 56
112. Yvan-Charvet L., Quignard-Boulangé A., Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney International 2011 79 2 162 168 2-s2.0-78650919357 10.1038/ki.2010.391
113. Weisinger H. S., Begg D. P., Egan G. F., Jayasooriya A. P., Lie F., Mathai M. L., Sinclair A. J., Wark J. D., Weisinger R. S., Angiotensin converting enzyme inhibition from birth reduces body weight and body fat in Sprague-Dawley rats. Physiology and Behavior 2008 93 4-5 820 825 2-s2.0-40749151810 10.1016/j.physbeh.2007.11.046 (Pubitemid 351381081)
114. Kurata A., Nishizawa H., Kihara S., Maeda N., Sonoda M., Okada T., Ohashi K., Hibuse T., Fujita K., Yasui A., Hiuge A., Kumada M., Kuriyama H., Shimomura I., Funahashi T., Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney International 2006 70 10 1717 1724 2-s2.0-33750604403 10.1038/sj.ki.5001810 (Pubitemid 44684802)
115. Yvan-Charvet L., Even P., Bloch-Faure M., Guerre-Millo M., Moustaid-Moussa N., Ferre P., Quignard-Boulange A., Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 2005 54 4 991 999 2-s2.0-15944377334 10.2337/diabetes.54.4.991 (Pubitemid 40446313)
116. Saiki A., Ohira M., Endo K., Koide N., Oyama T., Murano T., Watanabe H., Miyashita Y., Shirai K., Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus. Metabolism 2009 58 5 708 713 2-s2.0-64349083373 10.1016/j.metabol. 2009.01.013
117. Matsushita K., Wu Y., Okamoto Y., Pratt R. E., Dzau V. J., Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 2006 48 6 1095 1102 2-s2.0-33751090979 10.1161/01.HYP.0000248211.82232.a7 (Pubitemid 44772713)
118. Sydow M., Burchardi H., Zinserling J., Ische H., Crozier T. A., Weyland W., Improved determination of static compliance by automated single volume steps in ventilated patients. Intensive Care Medicine 1991 17 2 108 114 2-s2.0-0025979816
119. Ames B. N., Cathcart R., Schwiers E., Hochstein P., Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proceedings of the National Academy of Sciences of the United States of America 1981 78 11 6858 6862 2-s2.0-0019787519 (Pubitemid 12216861)
120. Brown C. M., Dulloo A. G., Montani J. P., Sugary drinks in the pathogenesis of obesity and cardiovascular diseases. International Journal of Obesity 2008 32 supplement 6 S28 S34 2-s2.0-57749099061 10.1038/ijo.2008.204
121. Palmer J. R., Boggs D. A., Krishnan S., Hu F. B., Singer M., Rosenberg L., Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Archives of Internal Medicine 2008 168 14 1487 1492 2-s2.0-49449100119 10.1001/archinte.168.14.1487